# Veralto (VLTO) — News

VLTO · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/vlto/news

## Recent headlines

- [United Therapeutics Corp - Liquidia to terminate ascent trial cohorts studying PH-ILD and cease data publication - SEC filing](https://www.ainvest.com/news/united-therapeutics-corp-liquidia-terminate-ascent-trial-cohorts-studying-ph-ild-cease-data-publication-sec-filing-2610) — AInvest Wire, Oct 14, 2026
- [Veralto: deal seen closing in 4Q](https://www.ainvest.com/news/veralto-deal-closing-4q-2608) — AInvest Wire, Aug 19, 2026
- [Veralto to buy CleanWater1](https://www.ainvest.com/news/veralto-buy-cleanwater1-2608) — AInvest Wire, Aug 19, 2026
- [VeraltO: expect total YoY core sales growth to accelerate to approximately 5% to 6% in second half of year](https://www.ainvest.com/news/veralto-expect-total-yoy-core-sales-growth-accelerate-approximately-5-6-year-2607) — AInvest Wire, Jul 28, 2026
- [Veralto sees FY adj EPS $4.35 to $4.43, saw $4.20 to $4.28](https://www.ainvest.com/news/veralto-sees-fy-eps-4-35-4-43-4-20-4-28-2607) — AInvest Wire, Jul 28, 2026
  Veralto Corp. (VTLO) has raised its fiscal year adjusted earnings per share (adj EPS) guidance to a range of $4.35 to $4.43, up from its previous forecast of $4.20 to $4.28. The updated outlook reflects improved operational performance and favorable market conditions. The company has not disclosed…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).